Childhood non-Hodgkin lymphoma

You are here: 

Survival statistics for childhood non-Hodgkin lymphoma

Survival statistics for childhood non-Hodgkin lymphoma (NHL) are very general estimates and must be interpreted very carefully. These statistics are based on the experience of groups of children and cannot be used to predict a particular child’s chances of survival.

There are many different ways to measure and report cancer survival statistics. Your child’s doctor can explain the statistics for childhood NHL and what they mean for your child.

Observed survival

Observed survival is also called overall survival. It is the percentage of children with a certain type of cancer who are expected to live for at least a specified period of time after their diagnosis. Doctors often use the observed survival rate when they talk about a prognosis.

The 5-year observed survival for NHL in children 0–14 years of age is 88%. This means that, on average, 88% of children diagnosed with NHL are expected to live at least 5 years after their diagnosis.

Observed survival does not consider the cause of death. But of the 12% of children who don’t survive 5 years, most die from the cancer rather than from other causes.

Survival by type

Survival varies with each type of NHL as well as by stage.

Generally, the earlier NHL is diagnosed and treated, the better the outcome.

There are no specific Canadian statistics available for the different types and stages of NHL in children. The following information comes from a variety of sources. It may include statistics from other countries that are likely to have similar outcomes as in Canada.

Childhood NHL survival by type
Type of childhood NHLStage5-year observed survival

Burkitt lymphoma

1 and 2


3 and 4


lymphoblastic lymphoma

1 and 2


3 and 4


diffuse large B-cell lymphoma

1 and 2


3 and 4


anaplastic large cell lymphoma

1 and 2


3 and 4


Questions about survival

Talk to your child’s doctor about their prognosis. A prognosis depends on many factors, including:

  • the child’s health history
  • the type of cancer
  • the stage
  • certain characteristics of the cancer
  • the treatments chosen
  • how the cancer responds to treatment

Only a doctor familiar with these factors can put all of this information together with survival statistics to arrive at a prognosis.


Photo of Claude Perreault Dr Perreault identified new molecules that may help make immunotherapies work for more people.

Read more

Reducing the burden of cancer

Icon - hand with dollar sign floating above it

Canadians can help CCS fund the best research and support people living with cancer by donating and volunteering.

Learn more